Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00814203
Other study ID # 2007H0248
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 2008
Est. completion date December 2010

Study information

Verified date October 2021
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.


Description:

To develop a cohort of COPD participants for study staff to determine the most likely candidates for future studies and to develop a repository of blood from subjects with COPD for future studies.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date December 2010
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following: - clinical history-a documented history of COPD, emphysema, or chronic bronchitis; - pulmonary function results (defined as an FEV1/FVC less than 0.7; - radiographic results (high-resolution CT findings of emphysema Exclusion Criteria: - in ability to give informed consent - prisoners - pregnancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States The Ohio State University Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Philip Diaz

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary This is a registry protocol to determine factors contributing to the development of chronic obstructive lung disease.
Secondary To develop a repository of blood from subjects with COPD for future studies. These studies may include evaluation of biologic markers of disease severity and progression.
See also
  Status Clinical Trial Phase
Withdrawn NCT01416701 - Vitamin D and Chronic Obstructive Lung Disease Phase 4
Completed NCT01362855 - Advance Care Planning Evaluation in Hospitalized Elderly Patients
Completed NCT00202150 - Primary Care Management/Action Plans for Advanced Chronic Diseases Phase 2/Phase 3
Recruiting NCT05227547 - Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease N/A
Withdrawn NCT02273349 - Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency N/A
Completed NCT00018408 - Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT02987439 - COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD N/A
Completed NCT01950936 - Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) Phase 2/Phase 3
Completed NCT01404000 - Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal Phase 2
Terminated NCT03811158 - The Edi Level and Cardiopulmonary Function Between HHHFNC and Unheated Humidified High-Flow Oxygen Mask in COPD N/A
Recruiting NCT01631162 - The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples N/A
Completed NCT01596023 - Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients N/A
Completed NCT01347931 - In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency N/A
Terminated NCT01712854 - Effects of Symbicort on the Ventilatory Kinematics Phase 4
Completed NCT02462343 - Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD N/A
Recruiting NCT06090149 - Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients N/A
Recruiting NCT02778802 - Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR N/A
Enrolling by invitation NCT02278107 - Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease N/A
Completed NCT01614951 - The Pulmonary Protection Trial Phase 4
Completed NCT01787097 - Effect of Symbicort ® on GR in Sputum in COPD Phase 4